599.47
Precedente Chiudi:
$598.08
Aprire:
$593.03
Volume 24 ore:
303.10K
Relative Volume:
1.09
Capitalizzazione di mercato:
$16.73B
Reddito:
$2.68B
Utile/perdita netta:
$460.40M
Rapporto P/E:
37.71
EPS:
15.8963
Flusso di cassa netto:
$711.00M
1 W Prestazione:
-3.14%
1M Prestazione:
+1.09%
6M Prestazione:
+20.29%
1 anno Prestazione:
+11.81%
Medpace Holdings Inc Stock (MEDP) Company Profile
Nome
Medpace Holdings Inc
Settore
Industria
Telefono
(513) 579-9911
Indirizzo
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings Inc
|
599.47 | 17.27B | 2.68B | 460.40M | 711.00M | 15.90 |
|
TMO
Thermo Fisher Scientific Inc
|
654.80 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
214.06 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
410.35 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
167.78 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
|
IQV
Iqvia Holdings Inc
|
258.21 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-18 | Aggiornamento | TD Cowen | Sell → Hold |
| 2026-02-13 | Aggiornamento | Jefferies | Hold → Buy |
| 2026-02-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-02 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Downgrade | UBS | Neutral → Sell |
| 2025-07-23 | Downgrade | TD Cowen | Hold → Sell |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-04-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-24 | Iniziato | Leerink Partners | Market Perform |
| 2024-10-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-27 | Downgrade | UBS | Buy → Neutral |
| 2024-09-25 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-01 | Iniziato | Truist | Hold |
| 2024-05-29 | Iniziato | TD Cowen | Buy |
| 2024-05-28 | Iniziato | Mizuho | Buy |
| 2024-04-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-18 | Iniziato | Deutsche Bank | Hold |
| 2024-02-15 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-27 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-07 | Iniziato | UBS | Sell |
| 2022-05-24 | Iniziato | Guggenheim | Neutral |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-10-02 | Aggiornamento | Truist | Hold → Buy |
| 2020-06-08 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Aggiornamento | SunTrust | Sell → Hold |
| 2020-04-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Downgrade | SunTrust | Hold → Sell |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2018-10-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-09-17 | Iniziato | SunTrust | Hold |
| 2018-07-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2017-07-10 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Medpace Holdings Inc Borsa (MEDP) Ultime notizie
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance
UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673 - Moomoo
UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $673 From $405 - Moomoo
Enterprise value to EBIT forward of Medpace Holdings, Inc. – HAN:01P - TradingView
Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today - Benzinga
Insider Decision: August J Troendle Offloads $1.59M Worth Of Medpace Holdings Stock - Benzinga
Long term debt to total assets ratio of Medpace Holdings, Inc. – HAN:01P - TradingView
Medpace stock coverage resumed at UBS with neutral rating - Investing.com
UBS Initiates Coverage of Medpace (MEDP) with Neutral Rating and $673 Price Target - GuruFocus
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Medpace Holdings Insider Sold Shares Worth $1,589,941, According to a Recent SEC Filing - marketscreener.com
At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan
Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria
Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com
Medpace Holdings CEO August J. Troendle sells $6.75m in stock By Investing.com - Investing.com South Africa
Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com
Medpace Holdings CEO August Troendle sells $44.4m stock By Investing.com - Investing.com South Africa
Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Medpace Holdings Inc For: 26 September By Investing.com - Investing.com Canada
Medpace CEO August Troendle sells $27.4m in company stock - Investing.com
Medpace CEO August Troendle sells $27.4m in company stock By Investing.com - Investing.com South Africa
Form 4 Medpace Holdings Inc For: 26 September - Investing.com India
CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan
Medpace Holdings, Inc. (MEDP) Stock forecasts - uk.finance.yahoo.com
Insider Transaction: August J Troendle Sells $44.43M Worth Of Medpace Holdings Shares - Benzinga
Have Insiders Sold Medpace Holdings Shares Recently? - simplywall.st
After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan
Medpace stock falls 2.07 percent as CEO sale surfaces - AD HOC NEWS
Medpace(MEDP.US) 10% Shareholder Sells US$44.43 Million in Common Stock - moomoo.com
Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan
MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile
Mizuho maintains Outperform on Medpace, raises target to $586 - scanx.trade
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 - Investing News Network
Medpace Holdings Q3FY26 Results: Earnings call set for Oct 22 - scanx.trade
Medpace Holdings President & CEO Trades $6.75M In Company Stock - Benzinga
Projected EPS and Revenue Gains Might Change The Case For Investing In Medpace Holdings (MEDP) - Yahoo Finance
Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? - Yahoo Finance
Medpace Holdings Insider Sold Shares Worth $6,749,952, According to a Recent SEC Filing - moomoo.com
Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Medpace (NASDAQ:MEDP) CEO Sells $6,749,952.00 in Stock - MarketBeat
Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - Stock Titan
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal
Medpace Holdings President & CEO Sold $15.36M In Company Stock - Benzinga
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Connect - ACCESS Newswire
Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - Stock Titan
Medpace Holdings (MEDP) insider exercises 3,000 options - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Medpace (MEDP) Retreats -0.57%, Breaching $586.11 Support Line 2026-09-16Bearish Sentiment - careplusvn.com
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP), Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc (MEDP) Stock Up 4.1% but GF Value Says Over - GuruFocus
Medpace Holdings Inc Azioni (MEDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medpace Holdings Inc Azioni (MEDP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Troendle August J. | President & CEO |
Sep 30 '26 |
Sale |
625.47 |
21,966 |
13,739,074 |
338,225 |
| Troendle August J. | President & CEO |
Sep 28 '26 |
Sale |
620.07 |
2,410 |
1,494,369 |
386,892 |
| Troendle August J. | President & CEO |
Sep 25 '26 |
Sale |
620.60 |
154 |
95,572 |
389,302 |
| Troendle August J. | President & CEO |
Sep 24 '26 |
Sale |
621.33 |
27,833 |
17,293,478 |
389,456 |
| Troendle August J. | President & CEO |
Sep 23 '26 |
Sale |
628.64 |
16,083 |
10,110,417 |
417,289 |
| Troendle August J. | President & CEO |
Sep 22 '26 |
Sale |
628.11 |
49,018 |
30,788,696 |
433,372 |
| Troendle August J. | President & CEO |
Sep 21 '26 |
Sale |
623.29 |
21,883 |
13,639,455 |
482,390 |
| Troendle August J. | President & CEO |
Sep 17 '26 |
Sale |
620.40 |
10,880 |
6,749,952 |
504,273 |
| Troendle August J. | President & CEO |
Sep 15 '26 |
Sale |
620.84 |
15,971 |
9,915,436 |
523,923 |
| Troendle August J. | President & CEO |
Sep 16 '26 |
Sale |
621.29 |
8,770 |
5,448,713 |
515,153 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):